Skip to content

Clareon CCWTT4 (UDI 00380652457897)Recalls & reported problems

Alcon Laboratories, Inc. · Clareon PanOptix Toric UVA · Class 3 · Implant

All models of Clareon (1142)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00380652457897), received between Apr 4, 2023 and Feb 21, 2025 — classified as 5 injuries, 1 malfunction.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 1 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 1 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Dislodged or Dislocated2
  • Malposition of Device2
  • Adverse Event Without Identified Device or Use Problem1
  • Defective Device1

Patient problems

  • Blurred Vision3
  • Visual Impairment2
  • Halo1
  • Insufficient Information1
  • Visual Disturbances1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 21, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A NON HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT HAD FOGGY AND GLARE ISSUES. THE IOL WAS EXCHANGED FOR NON COMPANY LENS MODEL 8 MONTHS AND 7 DAYS AFTER THE INITIAL IMPLANT PROCEDURE. CLINICAL REASON FOR EXPLANT WAS REPORTED AS IOL CALCULATIONS. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS PATIENT. THIS REPORT IS ASSOCIATED WITH THE RIGHT EYE. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Blurred Vision; Visual Disturbances

    MAUDE report 21434336 ↗
  • InjuryAug 13, 2024Malposition of Device; Malposition of Device

    A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED POOR VISION. CLINICAL REASON MENTIONED AS IMPLANTED LENS WAS DECENTERED. ON RE-RUNNING CALCULATIONS FOLLOWING EVALUATION, SURGEON ALSO DECIDED THAT ORIGINALLY PRESCRIBED TORICITY WAS INSUFFICIENT AND REQUESTED TO EXCHANGE T4 FOR T5. THE IOL WAS EXPLANTED AND EXCHANGED WITH ANOTHER LENS FOLLOWING THE SECONDARY IMPLANT PROCEDURE. ADDITIONAL INFORMATION RECEIVED STATING THAT THERE WAS NO PATIENT HARM.

    Patient problems: Visual Impairment

    MAUDE report 19973827 ↗
  • InjuryJul 29, 2024Defective Device; Defective Device

    ADDITIONAL INFORMATION WAS REQUESTED AND RECEIVED STATING THAT THE LENS WAS IMPLANTED BUT THEN EXPLANTED AND REPLACED AFTER LENS WOULD NOT REMAIN CENTERED IN PATIENTS EYE RELATED TO TERMINAL HAPTIC MISSING. BROUGHT BACK FOR SURGERY WITHIN 3 WEEK PERIOD TO REMOVE AND REPLACE. THE ISSUE WITH THE LENS WAS NOT DISCOVERED UNTIL THE POSTOPERATIVE PERIOD.

    Patient problems: Visual Impairment

    MAUDE report 19849651 ↗
  • InjuryJun 6, 2023Device Dislodged or Dislocated; Device Dislodged or Dislocated

    A CONSUMER REPORTED THAT AFTER INTRAOCULAR LENS (IOL) IMPLANTATION, THE PATIENT COULD NOT SEE CLEARLY MORE THAN FIVE FEET AWAY, THE VISION WAS BLURRY AT DISTANCE, AND PATIENT COULD NOT DRIVE SINCE THE SURGERY. THE PATIENT WAS GIVEN GLASSES AND THAT CLEARED THE DISTANCE VISION. PATIENT'S VISION WAS GREAT FOR READING NEAR AND INSIDE THE HOME. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND RECEIVED STATING- AFTER THE SURGERIES, THE SURGEON SAID PATIENT'S LENSES HAD "SHIFTED". THE SURGEON SAID THE VISION WOULD NOT IMPROVE AT DISTANCE. IT WAS TOLD THAT PATIENT WAS NOT NEURO-ADAPTING TO THE LENS AND MUST BE INTOLERANT. THE SURGEON PERFORMED YTTRIUM-ALUMINUM-GARNET (YAG) LASER IN THE RIGHT EYE, BUT PATIENT DID NOT FEEL THAT THE VISION WAS IMPROVED. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS PATIENT. THIS REPORT IS ASSOCIATED WITH THE RIGHT EYE.

    Patient problems: Blurred Vision

    MAUDE report 17070025 ↗
  • InjuryJun 6, 2023Device Dislodged or Dislocated; Device Dislodged or Dislocated

    A CONSUMER REPORTED THAT AFTER INTRAOCULAR LENS (IOL) IMPLANTATION, THE PATIENT COULD NOT SEE CLEARLY MORE THAN FIVE FEET AWAY, THE VISION WAS BLURRY AT DISTANCE, AND PATIENT COULD NOT DRIVE SINCE THE SURGERY. THE PATIENT WAS GIVEN GLASSES AND THAT CLEARED THE DISTANCE VISION. PATIENT'S VISION WAS GREAT FOR READING NEAR AND INSIDE THE HOME. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND RECEIVED STATING- AFTER THE SURGERIES, THE SURGEON SAID PATIENT'S LENSES HAD "SHIFTED". THE SURGEON SAID THE VISION WOULD NOT IMPROVE AT DISTANCE. IT WAS TOLD THAT PATIENT WAS NOT NEURO-ADAPTING TO THE LENS AND MUST BE INTOLERANT. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS PATIENT. THIS REPORT IS ASSOCIATED WITH THE LEFT EYE.

    Patient problems: Blurred Vision; Halo

    MAUDE report 17070018 ↗
  • MalfunctionApr 4, 2023Malposition of Device; Malposition of Device

    A SURGEON REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT VISION WAS 20/25 WITH AUTOREFRACTION +1.00 -0.75 X 167, AT 2 WEEKS POST OP UNCORRECTED VISION DECREASED TO 20/80 WITH MANIFEST REFRACTION +1.25 -3.00 X15 WITH CORRECTED VISION 20/15. THE PLANNED AXIS OF IOL WAS 103DEGREES. AT 2 WEEKS THE IOL WAS FOUND TO HAVE ROTATED TO AXIS 180. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Insufficient Information

    MAUDE report 16675138 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page